Dr. Suganya Manoharan, MD

Dr. Manoharan practices at Synergy Laboratories, Inc. in Mobile, Alabama.

Dr. Manoharan's NPI, 1053805291, was assigned on June 20, 2018. Dr. Manoharan holds Alabama license MD.48974.

Dr. Manoharan's primary practice is Synergy Laboratories, Inc., at 5570 Rangeline Rd, Mobile, AL 36619 in Mobile County. The practice phone is (251) 662-9760.

Dr. Manoharan's primary practice is Synergy Laboratories, Inc. in Mobile, Alabama. Dr. Manoharan is also affiliated with USA Health University Hospital. The medical group on file is USA Health Physician Billing. Dmand AI also links Dr. Manoharan to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manoharan practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Manoharan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Manoharan is licensed in Alabama.

CMS data shows 103 Medicare services from Dr. Manoharan across 2 procedure codes in 2024, for 122 Medicare patients. Medicare paid $5,990 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 122 Medicare patients who saw Dr. Manoharan in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manoharan's median patient age at 71, with 55% women.

In 2024, Dr. Manoharan wrote 349 Medicare Part D claims for 59 patients. 81% of them were for generic drugs. CMS names the drug for 205 of them, across 9 drugs with 11 or more claims each, at $31,177 in total drug cost. In 2023, CMS named 198 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Manoharan for performance year 2024, reported through an alternative payment model (APM). Dr. Manoharan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Manoharan in 2024. Dr. Manoharan's most frequent co-authors are Arij Azhar, MD, Louis N. Gerolemou, DO and Gaurav Singh Parhar, MD.

CMS Open Payments shows 15 general payments to Dr. Manoharan from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $270.